A qualitative study on decision-making about BRCA1/2 testing in Italian women

被引:11
|
作者
Battistuzzi, Linda [1 ,2 ]
Franiuk, Marzena [3 ]
Kasparian, Nadine [4 ,5 ,6 ]
Rania, Nadia [7 ]
Migliorini, Laura [7 ]
Varesco, Liliana [3 ]
机构
[1] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn, Via Opera Pia 13, I-16145 Genoa, Italy
[2] Univ Genoa, Dept Internal Med & Med Specialties, Genoa, Italy
[3] San Martino Polyclin Hosp, Unit Hereditary Canc, Genoa, Italy
[4] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA
[5] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA
[6] UNSW Sydney, UNSW Med, Sch Womens & Childrens Hlth, Discipline Paediat, Sydney, NSW, Australia
[7] Univ Genoa, Dept Educ Sci, Genoa, Italy
关键词
BRCA1; 2; culture; decision-making; ethics; genetic counseling; qualitative research; BREAST-CANCER; FAMILY; COMMUNICATION; INFORMATION; MUTATION; RESPONSIBILITY; FAMILIALISM; EXPERIENCES; VARIETIES; ATTITUDES;
D O I
10.1111/ecc.13083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective In the era of cancer panel testing, new models of genetic counselling providing effective decision-making support are needed. As little is known about Southern European patients' and families' needs and experiences in this regard, we explored Italian women's experiences of clinical BRCA1/2 counselling and testing. Methods We interviewed 19 Italian women with a strong family history but no personal history of cancer who had had clinical BRCA1/2 testing. Interviews were recorded and transcribed, and qualitative data were organised into themes. Results Most respondents had decided to pursue testing before pre-test counselling. Although half the sample reported having reached the decision without thinking through its implications, most participants qualified their choice as unequivocally "the right one." Conclusion A subset of Italian women may arrive at their first cancer genetic consultation having already made a firm decision about testing. To empower women's decision-making, new models of cancer genetic counselling could usefully take into account differences in how they approach the testing process. This includes understanding decision-making from different cultural perspectives. In familistic countries like Italy, for example, decisional support may involve exploring widely shared assumptions regarding responsibilities towards family members and the prioritisation of family over self.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community
    Yi, Haeseung
    Trivedi, Meghna S.
    Crew, Katherine D.
    Schechter, Isaac
    Appelbaum, Paul S.
    Chung, Wendy K.
    Allegrante, John P.
    Kukafka, Rita
    PUBLIC HEALTH GENOMICS, 2024, 27 (01) : 57 - 67
  • [32] Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making
    Kautz-Freimuth, Sibylle
    Redaelli, Marcus
    Rhiem, Kerstin
    Vodermaier, Andrea
    Krassuski, Lisa
    Nicolai, Kathrin
    Schnepper, Miriam
    Kuboth, Violetta
    Dick, Julia
    Vennedey, Vera
    Wiedemann, Regina
    Schmutzler, Rita
    Stock, Stephanie
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2021, 21 (01)
  • [33] Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making
    Sibylle Kautz-Freimuth
    Marcus Redaèlli
    Kerstin Rhiem
    Andrea Vodermaier
    Lisa Krassuski
    Kathrin Nicolai
    Miriam Schnepper
    Violetta Kuboth
    Julia Dick
    Vera Vennedey
    Regina Wiedemann
    Rita Schmutzler
    Stephanie Stock
    BMC Medical Informatics and Decision Making, 21
  • [34] Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study®
    Michelle I. Silver
    William Klein
    Goli Samimi
    Lori Minasian
    Jennifer Loud
    Megan C. Roberts
    Breast Cancer Research and Treatment, 2019, 173 : 719 - 726
  • [35] Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study®
    Silver, Michelle I.
    Klein, William
    Samimi, Goli
    Minasian, Lori
    Loud, Jennifer
    Roberts, Megan C.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (03) : 719 - 726
  • [36] Reproductive decision making and partnering in BRCA1/2 mutation carriers
    DiSilvestro, J. B.
    Haddad, J.
    Robison, K. M.
    Beffa, L. B.
    Laprise, J.
    Wilbur, J. Scalia
    Raker, C.
    Hofstatter, E.
    Dalela, D.
    Brown, A. K.
    Bradford, L.
    Toland, M.
    Stuckey, A. R.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 260 - 261
  • [37] Complex Medical Decision-Making for a Trans-Feminine Youth with a BRCA1 Mutation
    Wolf-Gould, Carolyn S.
    Riley, Moira R.
    Carswell, Jeremi M.
    LGBT HEALTH, 2018, 5 (04) : 221 - 225
  • [38] Factors associated with decisions about clinical BRCA1/2 testing
    Armstrong, K
    Calzone, K
    Stopfer, J
    Fitzgerald, G
    Coyne, J
    Weber, B
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2000, 9 (11) : 1251 - 1254
  • [39] Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer
    Daniels, Molly S.
    Urbauer, Diana L.
    Stanley, Jennifer L.
    Johnson, Kristin G.
    Lu, Karen H.
    GENETICS IN MEDICINE, 2009, 11 (09) : 624 - 628
  • [40] Is it time to offer BRCA1 and BRCA2 testing to all Jewish women?
    Metcalfe, K. A.
    Eisen, A.
    Lerner-Ellis, J.
    Narod, S. A.
    CURRENT ONCOLOGY, 2015, 22 (04) : E233 - E236